Literature DB >> 22274400

Pick your poison: the Ripoptosome, a cell death platform regulating apoptosis and necroptosis.

Maria Feoktistova1, Peter Geserick, Diana Panayotova-Dimitrova, Martin Leverkus.   

Abstract

At an unbelievable pace, recent evidence has emerged that demonstrates the importance of a programmed form of necrosis (necroptosis) in physiology, pathophysiology and embryonic development. It is clear that the understanding of the intracellular control of necroptosis as compared to caspase-dependent apoptosis is of paramount importance. Tumorigenesis, immune surveillance of cancer and pathogen-induced disease, to name only a few, appear to be affected by the mode of cell death in vivo. Here, we discuss the Ripoptosome, a newly defined 2 MDa intracellular signalling complex that can be formed upon genotoxic stress or loss of inhibitor-of apoptosis proteins (IAPs). The Ripoptosome is a signaling platform that can switch modes between apoptotic and necroptotic cell death. In this report, we extend our recent studies and further the notion that the stoichiometric balance between RIP1 and cIAPs is critical for Ripoptosome formation. Furthermore, we demonstrate the critical relevance of the balance of expression levels of short (cFLIPS) or viral (vFLIP) forms of FLIP and RIP3 kinase for the spontaneous execution of necroptosis whenever cIAPs are absent in the cells. Our study thus supports and extends the intriguing role of the Ripoptosome for the regulation of apoptosis and necroptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274400     DOI: 10.4161/cc.11.3.19060

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

Review 1.  Cell death controlling complexes and their potential therapeutic role.

Authors:  Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

2.  Mis-trafficking of endosomal urokinase proteins triggers drug-induced glioma nonapoptotic cell death.

Authors:  Nagarekha Pasupuleti; Ana Cristina Grodzki; Fredric Gorin
Journal:  Mol Pharmacol       Date:  2015-01-29       Impact factor: 4.436

Review 3.  Aging and uremia: Is there cellular and molecular crossover?

Authors:  William E White; Muhammad M Yaqoob; Steven M Harwood
Journal:  World J Nephrol       Date:  2015-02-06

4.  Identification and analysis of dominant negative mutants of RIP1 DD that disrupt RIPoptosome core formation.

Authors:  Hyun Ji Ha; Hyun Ho Park
Journal:  Mol Biol Rep       Date:  2018-08-23       Impact factor: 2.316

Review 5.  Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death.

Authors:  James M Murphy; John Silke
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

6.  Activation of autophagy in photoreceptor necroptosis after experimental retinal detachment.

Authors:  Kai Dong; Zi-Cheng Zhu; Feng-Hua Wang; Gen-Jie Ke; Zhang Yu; Xun Xu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

7.  Pivotal Role of Receptor-Interacting Protein Kinase 1 and Mixed Lineage Kinase Domain-Like in Neuronal Cell Death Induced by the Human Neuroinvasive Coronavirus OC43.

Authors:  Mathieu Meessen-Pinard; Alain Le Coupanec; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 8.  Necroptosis: The Trojan horse in cell autonomous antiviral host defense.

Authors:  Edward S Mocarski; Hongyan Guo; William J Kaiser
Journal:  Virology       Date:  2015-03-24       Impact factor: 3.616

9.  RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion-induced danger signal release.

Authors:  Hilary Faust; Lk Metthew Lam; Meghan J Hotz; Danielle Qing; Nilam S Mangalmurti
Journal:  Vox Sang       Date:  2020-07-07       Impact factor: 2.144

Review 10.  Viral modulation of programmed necrosis.

Authors:  William J Kaiser; Jason W Upton; Edward S Mocarski
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.